Guy M. Middleton

Obstetrics and Gynecology

1108 Ross Clark Cir
Dothan, AL 36301

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infants.

Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infants.

Journal: Human vaccines & immunotherapeutics

Published: March 02, 2026

Showing 1-1 of 1

Last Updated: 09/26/2026